DrugPatentWatch Database Preview
Drugs in Development Information for Nedaplatin
» See Plans and Pricing
What is the development status for investigational drug Nedaplatin?
Nedaplatin is an investigational drug.
There have been 42 clinical trials for Nedaplatin.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2013.
The most common disease conditions in clinical trials are Carcinoma, Nasopharyngeal Neoplasms, and Esophageal Neoplasms. The leading clinical trial sponsors are Sun Yat-sen University, Chinese Academy of Medical Sciences, and Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.
There are two US patents protecting this investigational drug and two international patents.
Summary for Nedaplatin
| US Patents | 2 |
| International Patents | 2 |
| US Patent Applications | 7 |
| WIPO Patent Applications | 624 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2013-12-01) |
| Vendors | 59 |
Recent Clinical Trials for Nedaplatin
| Title | Sponsor | Phase |
|---|---|---|
| Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | Phase 3 |
| Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC | Sun Yat-sen University | Phase 2 |
| Split-course Thoracic Radiotherapy Combined With Nab-paclitaxel Plus Nedaplatin for Local Advanced NSCLC With Impaired Baseline Pulmonary Function | Sun Yat-sen University | Phase 2 |
Clinical Trial Summary for Nedaplatin
Top disease conditions for Nedaplatin
Top clinical trial sponsors for Nedaplatin
US Patents for Nedaplatin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Nedaplatin | Start Trial | Estrogen-linked platinum (II) complexes as anticancer agents | Berube; Gervais (Trois-Riviere, CA) | Start Trial |
| Nedaplatin | Start Trial | Macromolecular platinum chelates | Access Pharmaceuticals, Inc. (Dallas, TX) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Nedaplatin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Nedaplatin | Canada | CA2423454 | 2022-03-28 | Start Trial |
| Nedaplatin | World Intellectual Property Organization (WIPO) | WO2005002508 | 2023-06-11 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
